m.achebe
TL2 · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 5 September 2025 · last posted 3d
70 posts, newest first. Showing up to 150.
-
The anatomy of a question that gets answered within an hour Replied, post #125 · Start Here › How to Ask · 25 Jul 2026 · 17 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
What is genuinely unknown about long-term amylin agonism Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 14 Jul 2026 · 5 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #2 · Compounds › Oral incretins · 13 Jul 2026 · 7 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #41 · Access › Pricing · 10 Jul 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Language barriers in accessing a prescription abroad Replied, post #2 · marked as the solution · Access › International · 5 Jul 2026 · 13 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #53 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes Post #51 put the caveat in the right place and I want to underline it. Endotoxin sits at the boundary between what this community can usefully discuss and what it…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #32 · Sourcing › Independent verification · 21 Jun 2026 · 12 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #57 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 0 likes Whatever the answer on Area percent versus weight percent turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #18 · Access › Insurance & coverage · 13 Jun 2026 · 14 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Coming back to: Time to steady state after a dose increase Replied, post #71 · Pharmacology › Pharmacokinetics · 7 Jun 2026 · 18 likes Thank you for the correction. I would rather find out here than later.
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #130 · Practice › Storage & stability · 7 Jun 2026 · 8 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Designing a personal experiment that could change your mind — one year on Replied, post #55 · Research Methods › N-of-1 designs · 3 Jun 2026 · 4 likes Post #53 is the version of this I will quote in future. One addition. Regression to the mean explains a great many personal experiments. People start when things are at…
-
Batch numbers that do not match the vial label — what changed since Replied, post #19 · Sourcing › Red flags · 22 May 2026 · 3 likes Everything in post #15 holds. The case it does not cover is the one I have. The strongest single signal available cheaply is what happens when you ask a technical…
-
Reading a trial's population section before its results Replied, post #6 · Evidence › Trials · 8 May 2026 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #90 · Practice › Interactions · 22 Apr 2026 · 14 likes My experience of Metformin co-administration contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #67 · Practice › Side effects · 11 Apr 2026 · 24 likes A note on scope: what I am saying about Dizziness on standing applies to the case in the first post and I would not extend it further without checking.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #84 · Practice › Dosing & titration · 1 Apr 2026 · 0 likes Post #81 answers the question as asked. The question underneath it is different. If you are stepping up mainly because the schedule says so rather than because the…
-
Managing an unplanned gap in supply Replied, post #73 · Access › Shortages · 25 Mar 2026 · 4 likes The most useful thing anyone has posted about managing an unplanned gap in this category was a table of what had been measured and by whom. That is what I would want…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #59 · Practice › Interactions · 22 Mar 2026 · 23 likes This is the sort of exchange that makes the archive worth searching.
-
Second pass at: Identical chromatograms across two different lots Replied, post #75 · Sourcing › Red flags · 18 Mar 2026 · 9 likes Nothing here should be read as an accusation against a named company, and the guidelines exist so that reports remain reports. Written from notes rather than memory,…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #51 · Compounds › Repair & healing peptides · 13 Mar 2026 · 16 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Measurement error in home scales, with a worked standard deviation Replied, post #23 · Research Methods › Statistics · 13 Mar 2026 · 0 likes A standard deviation describes the spread of individuals and a standard error describes the precision of the mean. Quoting one where the other belongs changes the…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #62 · Regional › UK & Ireland · 3 Mar 2026 · 8 likes Members outside these two jurisdictions reading this thread should note that none of it transfers, including the parts that sound general. I have deliberately not…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #60 · Evidence › Study critique · 17 Feb 2026 · 19 likes Post #56 and I disagree about the size of the effect, not about the direction. Per-protocol and intention-to-treat analyses answer different questions and neither is…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #6 · Analytics › Impurities & related substances · 6 Feb 2026 · 18 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
-
Research-use-only labelling: what it means and what it does not Replied, post #98 · Sourcing › Regulatory · 5 Feb 2026 · 0 likes The reason research-use-only labelling keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
The headache that turns out to be dehydration Replied, post #144 · Nutrition & Training › Hydration & electrolytes · 18 Jan 2026 · 20 likes Cramping is the symptom most confidently attributed to electrolytes and has the weakest evidence linking it to them.
-
A partial dose because the pen emptied mid-injection Replied, post #14 · Practice › Administration · 7 Jan 2026 · 26 likes Speaking only to partial dose because the pen as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
Request: a diff view for wiki revisions — the long version Replied, post #93 · Meta › Feature requests · 2 Jan 2026 · 9 likes The question underneath diff view for wiki revisions is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #22 · Regional › UK & Ireland · 29 Dec 2025 · 6 likes Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant…
-
Angle of injection and whether 90 degrees is always right Replied, post #59 · Practice › Administration · 2 Dec 2025 · 0 likes Practical answer on angle of injection, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
-
Micro-titration: a disputed topic, argued properly Replied, post #6 · Practice › Dosing & titration · 25 Nov 2025 · 0 likes Post #4 is the version of this I will quote in future. One addition. Taking micro-titration seriously for a moment rather than deflecting: the honest position is that…
-
DXA precision and the least significant change for lean mass Replied, post #5 · Outcomes › Body composition · 17 Nov 2025 · 0 likes Adding the measurement that post #4 says would settle it. Where a scan disagrees with the mirror over a short period, the scan's precision limits are usually the…
-
Reading an interaction checker output critically Replied, post #45 · Practice › Interactions · 17 Nov 2025 · 2 likes I came in to disagree and I am leaving without a disagreement.
-
Run-in periods and the population they select Replied, post #22 · Evidence › Trials · 14 Nov 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
High-resolution MS on aggregates and what it can see Replied, post #116 · Analytics › Mass spectrometry · 9 Nov 2025 · 1 like This is the answer, and the reason it is the answer is the more useful part.
-
How to ask about something you suspect is a bad idea Replied, post #18 · Start Here › How to Ask · 21 Oct 2025 · 22 likes This settles it for me, at least until somebody posts a reason it should not.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #84 · Practice › Storage & stability · 6 Oct 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #83 · Evidence › Preprints · 2 Oct 2025 · 0 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
-
Second pass at: Programming during a large energy deficit Replied, post #17 · Nutrition & Training › Resistance training · 24 Sep 2025 · 6 likes Post #15 and I disagree about the size of the effect, not about the direction. Anybody returning after a break should expect to start lower than they left, and…
-
Reading a supplier's product description as a marketing document Replied, post #72 · Compounds › Other compounds · 18 Sep 2025 · 1 like Post #70 is the version of this I will quote in future. One addition. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #60 · Practice › Administration · 13 Sep 2025 · 4 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Titles that describe the question, not the situation Replied, post #74 · Start Here › How to Ask · 18 Aug 2025 · 2 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #3 · marked as the solution · Analytics › HPLC & UHPLC · 14 Aug 2025 · 6 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
A preprint whose numbers changed substantially at publication Replied, post #17 · Evidence › Preprints · 12 Aug 2025 · 1 like Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim. A guess,…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #28 · Compounds › Repair & healing peptides · 8 Aug 2025 · 0 likes The useful distinction on BPC-157 is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
-
What a documentation review can and cannot tell you Replied, post #55 · Sourcing › Independent verification · 31 Jul 2025 · 9 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Guidelines revision: what changed and why — one year on Replied, post #4 · Meta › Announcements · 30 Jul 2025 · 30 likes Where I part company with the opening post, and it is a narrow parting. Thank you for announcing it in advance rather than after. The number of places that do the…
-
Coming back to: When "no data" is the complete and final answer Replied, post #56 · Compounds › Other compounds · 23 Jul 2025 · 9 likes Worth separating two things that post #52 runs together. The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts.…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #95 · Nutrition & Training › Protein & intake · 15 Jun 2025 · 22 likes Reading this Tracking intake thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Trial registration and comparing the protocol with the paper Replied, post #14 · Evidence › Trials · 13 Jun 2025 · 1 like I had written a reply contradicting post #11 and deleted it. Here is what survived. Funding and trial conduct should be stated and are a weak predictor of anything on…
-
Revisiting: German, French and Dutch differences, compared Replied, post #29 · Regional › European Union · 4 Jun 2025 · 5 likes Something worth flagging about German: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Pre-registering a personal experiment, seriously Replied, post #80 · Research Methods › N-of-1 designs · 1 Jun 2025 · 0 likes The interesting personal experiments are the ones where the answer was no. They are also the ones least likely to be written up. The conclusion is tentative; the…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #79 · Practice › Reconstitution · 1 Jun 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That matches…
-
Asking about a compound your prescriber has not heard of Replied, post #41 · Clinical › Prescriber conversations · 17 May 2025 · 18 likes The most useful question anyone here has reported asking: what would make you change your mind about this?
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #130 · Documentation › Doc review · 29 Apr 2025 · 10 likes What I would want before treating draft on reconstitution arithmetic as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
-
Washout: how long is long enough, and for what purpose Replied, post #18 · Pharmacology › Pharmacokinetics · 15 Apr 2025 · 20 likes The most useful reply I ever got about washout was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Follow-up: What other technical communities get right that we do not Started this topic · Lounge › Off topic · 16 Jan 2025 · 19 likes What other technical communities get right that we do not I have a specific reason for asking rather than idle curiosity, and the context is below. A digression I have…
-
Building a sensible monitoring schedule with your prescriber Replied, post #47 · Clinical › Bloodwork · 20 Dec 2024 · 0 likes I had written a reply contradicting post #45 and deleted it. Here is what survived. Summarising the building a sensible monitoring schedule thread so far, since it is…
-
What we do not know about retatrutide, listed explicitly Replied, post #20 · Compounds › Retatrutide · 13 Dec 2024 · 3 likes Coming back to post #18, because the follow-up matters more than the original answer. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #70 · Clinical › Special populations · 25 Nov 2024 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #29 · Compounds › Tirzepatide · 9 Nov 2024 · 5 likes On post #25 — agreed on the reasoning, with one qualification. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #21 · Compounds › Secretagogues & GH axis · 9 Nov 2024 · 0 likes Post #20 put the caveat in the right place and I want to underline it. On analysis: these are short peptides and generally straightforward chromatographically, which…
-
Irish differences from the UK position Replied, post #37 · Regional › UK & Ireland · 14 Oct 2024 · 0 likes Posting my irish differences numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #51 · Clinical › Bloodwork · 23 Sep 2024 · 25 likes Taking bring a laboratory seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #100 · Nutrition & Training › Hydration & electrolytes · 17 Sep 2024 · 14 likes The most useful posts here describe what was measured, what was changed, and what happened, in that order. The claim is narrower than it sounds, and deliberately so.
-
Circumference measurements as a poor man's composition estimate Replied, post #110 · Outcomes › Body composition · 30 Aug 2024 · 11 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #54 · Analytics › COA interpretation · 12 Aug 2024 · 31 likes Understood. Thank you for being specific about the limits of it.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #14 · Practice › Dosing & titration · 17 Jun 2024 · 6 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Cold packs, phase-change material, and what survives ten days Replied, post #13 · Sourcing › Logistics · 14 Jun 2024 · 3 likes Delivery to an address where somebody is present is worth more for cold-chain material than any packing decision available to the supplier. The rule of thumb is fine;…